Skip to main content
. 2020 Apr 8;23(4):388–394. doi: 10.1089/jmf.2018.0197

FIG. 3.

FIG. 3.

Latency to platform by comparison between days 1 and 5 among the groups of control, EO100 mg/kg, scopolamine, mecamylamine, and their combinations with EO100 mg/kg (E. oleracea) and rivastigmine. *P < .05 comparison of all groups to day 1. Riva, rivastigmine.